Australian Clinical Labs Limited

ASX:ACL Stock Report

Mkt Cap: AU$616.5m

Australian Clinical Labs Dividend

What is Australian Clinical Labs's current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


17.26%

Current Dividend Yield

Dividend Yield vs Market

Australian Clinical Labs Dividend Yield vs Market
How does ACL dividend yield compare to the market?
SegmentDividend Yield
Company (ACL)17.3%
Market Bottom 25% (AU)2.6%
Market Top 25% (AU)6.7%
Industry Average (Healthcare)2.7%
Analyst forecast in 3 Years (ACL)4.3%

Notable Dividend: ACL's dividend (17.26%) is higher than the bottom 25% of dividend payers in the Australian market (2.56%).

High Dividend: ACL's dividend (17.26%) is in the top 25% of dividend payers in the Australian market (6.67%)


Stability and Growth of Payments

How stable has Australian Clinical Labs's dividend per share been in the past?
MonthDividend Per Share (annual)Avg. Yield (%)
6/30/20250.134
6/30/20240.136
6/30/20230.146
1/26/20230.5317.26
8/11/20220.5315.23
2/23/20220.244.83

Stable Dividend: Too early to tell whether ACL's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if ACL's dividend payments are increasing as they only just started paying a dividend.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (59.9%), ACL's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (40.5%), ACL's dividend payments are well covered by cash flows.


Discover strong dividend paying companies